Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97


Systems and Network Pharmacology Approaches to Cancer Stem Cells Research and Therapy.

Muqbil I, Bao GW, El-Kharraj R, Shah M, Mohammad RM, Sarkar FH, Azmi AS.

J Stem Cell Res Ther. 2012 Dec 16;Suppl 7(5). pii: 10413.


Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).

Martin-Castillo B, Oliveras-Ferraros C, Vazquez-Martin A, Cufí S, Moreno JM, Corominas-Faja B, Urruticoechea A, Martín ÁG, López-Bonet E, Menendez JA.

Cell Cycle. 2013 Jan 15;12(2):225-45. doi: 10.4161/cc.23274. Epub 2012 Jan 15.


Pancreatic cancer stem cells.

Lee CJ, Dosch J, Simeone DM.

J Clin Oncol. 2008 Jun 10;26(17):2806-12. doi: 10.1200/JCO.2008.16.6702. Review.


Secretome protein signature of human pancreatic cancer stem-like cells.

Brandi J, Dalla Pozza E, Dando I, Biondani G, Robotti E, Jenkins R, Elliott V, Park K, Marengo E, Costello E, Scarpa A, Palmieri M, Cecconi D.

J Proteomics. 2016 Mar 16;136:1-12. doi: 10.1016/j.jprot.2016.01.017. Epub 2016 Feb 2.


Cancer stem cells don't waste their time cleaning-low proteasome activity, a marker for cancer stem cell function.

Lenos KJ, Vermeulen L.

Ann Transl Med. 2016 Dec;4(24):519. doi: 10.21037/atm.2016.11.81.


Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.

Leon G, MacDonagh L, Finn SP, Cuffe S, Barr MP.

Pharmacol Ther. 2016 Feb;158:71-90. doi: 10.1016/j.pharmthera.2015.12.001. Epub 2015 Dec 17. Review.


Cancer stem cells and their mechanism of chemo-radiation resistance.

Kim Y, Joo KM, Jin J, Nam DH.

Int J Stem Cells. 2009 May;2(2):109-14. Review.


Heterogeneity and targeting of pancreatic cancer stem cells.

Penchev VR, Rasheed ZA, Maitra A, Matsui W.

Clin Cancer Res. 2012 Aug 15;18(16):4277-84. doi: 10.1158/1078-0432.CCR-11-3112. Review.


Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.

Jung Y, Park H, Zhao HY, Jeon R, Ryu JH, Kim WY.

Mol Cells. 2014 Jul;37(7):547-53. doi: 10.14348/molcells.2014.0158. Epub 2014 Jul 31.


Cancer stem cells: progress and challenges in lung cancer.

Templeton AK, Miyamoto S, Babu A, Munshi A, Ramesh R.

Stem Cell Investig. 2014 Apr 15;1:9. doi: 10.3978/j.issn.2306-9759.2014.03.06. eCollection 2014. Review.


A concise review on the current understanding of pancreatic cancer stem cells.

Vaz AP, Ponnusamy MP, Seshacharyulu P, Batra SK.

J Cancer Stem Cell Res. 2014;2. pii: e1004.


Insights into the cell of origin in breast cancer and breast cancer stem cells.

Lindeman GJ, Visvader JE.

Asia Pac J Clin Oncol. 2010 Jun;6(2):89-97. doi: 10.1111/j.1743-7563.2010.01279.x. Review.


Drug discovery approaches to target Wnt signaling in cancer stem cells.

Curtin JC, Lorenzi MV.

Oncotarget. 2010 Nov;1(7):552-66. Review.


Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.

Chanmee T, Ontong P, Kimata K, Itano N.

Front Oncol. 2015 Aug 10;5:180. doi: 10.3389/fonc.2015.00180. eCollection 2015. Review.


The secretome of colon cancer stem cells contains drug-metabolizing enzymes.

Emmink BL, Verheem A, Van Houdt WJ, Steller EJ, Govaert KM, Pham TV, Piersma SR, Borel Rinkes IH, Jimenez CR, Kranenburg O.

J Proteomics. 2013 Oct 8;91:84-96. doi: 10.1016/j.jprot.2013.06.027. Epub 2013 Jul 5.


Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.

Takebe N, Miele L, Harris PJ, Jeong W, Bando H, Kahn M, Yang SX, Ivy SP.

Nat Rev Clin Oncol. 2015 Aug;12(8):445-64. doi: 10.1038/nrclinonc.2015.61. Epub 2015 Apr 7. Review.


Novel therapeutic strategies for targeting liver cancer stem cells.

Oishi N, Wang XW.

Int J Biol Sci. 2011 Apr 26;7(5):517-35. Review.


Cancer Stem Cells in the Thyroid.

Nagayama Y, Shimamura M, Mitsutake N.

Front Endocrinol (Lausanne). 2016 Feb 29;7:20. doi: 10.3389/fendo.2016.00020. eCollection 2016. Review.


The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy.

O'Flaherty JD, Barr M, Fennell D, Richard D, Reynolds J, O'Leary J, O'Byrne K.

J Thorac Oncol. 2012 Dec;7(12):1880-90. doi: 10.1097/JTO.0b013e31826bfbc6. Review.


Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.

Zakaria N, Yusoff NM, Zakaria Z, Lim MN, Baharuddin PJ, Fakiruddin KS, Yahaya B.

BMC Cancer. 2015 Feb 25;15:84. doi: 10.1186/s12885-015-1086-3.

Supplemental Content

Support Center